TransUnion TRU Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss

Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss at other companies

DuPont de Nemours, Inc.DD

$0—

CDWCDW

$24.53M—

Encompass Health CorporationEHC

$0—

Penske Automotive GroupPAG

$4M—

AlbemarleALB

$0—

American Healthcare REITAHR

——

Other financials

Income statement

See full

Revenue$1.2B+13.7%

Operating income$244.8M-3.8%

Net income$397.1M+168%

EPS (diluted)$2.04+172%

Balance sheet

See full

Cash & equivalents$732.5M+20.1%

Total debt$5.6B+9.2%

Total equity$4.8B+8.4%

Total assets$12.0B+10.0%

Cash flow

See full

Operating cash flow$84.2M+60.4%

CapEx$65.2M-4.7%

Free cash flow$19.0M+219%

Valuation

See full

Market cap$12.45B-17.6%

Enterprise value$17.35B-12.0%

P/E17.7×-23.5×

P/S2.6×-0.9×

Profitability

See full

Gross margin59.8%—

Operating margin17.9%0.0pp

Net margin14.9%+6.3pp

FCF margin14.7%+2.8pp

Returns & leverage

See full

Return on equity15.4%+6.7pp

Debt / equity1.2×0.0×

Current ratio1.9×-0.1×

Where this comes from

Reported directly by TransUnion in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss.

The official record: TransUnion’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransUnion's business combination step acquisition equity interest in acquiree remeasurement gain or loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TransUnion's business combination step acquisition equity interest in acquiree remeasurement gain or loss?: TransUnion (TRU) reported business combination step acquisition equity interest in acquiree remeasurement gain or loss of $225.5M in Q1 2026.